WAT Waters Corporation

Q1 2025 10-Q

Filed: May 6, 2025Period ending Mar 29, 2025

Health Care

Laboratory Analytical InstrumentsSEC EDGAR

Waters Corporation (WAT) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 6, 2025 for the fiscal period ending Mar 29, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Risk Factors

• No new or amended risk factors disclosed this quarter, consistent with 10-K for year ended Dec 31, 2024
• Continued exposure to operational risks including supply chain disruptions and manufacturing delays impacting product availability

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$662M

▲ +3.9% YoY

Net Income

$121M

▲ +18.8% YoY

Net Margin

18.3%

▲ +230bp YoY

Source: XBRL data from Waters Corporation Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Waters Corporation Quarterly Reports

Q3 2025 10-Q

Q2 2025 10-Q

Get deeper insights on Waters Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.